Both in Pharmaceuticals
ANI Pharmaceuticals vs Nuvation Bio
Over the past year ANIP returned −23.3% and NUVB returned −9.8%; their daily moves had a correlation of 0.02.
ANIP −23.3% NUVB −9.8%Growth of $1, one year, split-adjusted
| Metric | ANIP | NUVB |
|---|---|---|
| Price | $72.16 | $4.67 |
| Market cap | $1.66B | $1.64B |
| Today | −0.17% | −0.53% |
| 1 month | +0.9% | −4.4% |
| 6 months | −14.2% | −7.4% |
| Year to date | −8.6% | −47.9% |
| 1 year | −23.3% | −9.8% |
| Revenue growth (YoY) | +25.9% | +555.6% |
| Gross margin | 62.4% | 73.0% |
| Net margin | 8.6% | −198.3% |
| P/E (TTM) | 16.6× | — |
| Price / sales | 1.7× | 9.6× |
| Net cash | -$234.7M | $399.4M |
| Dividend yield | — | — |
| Volatility (60d) | 26.7% | 50.7% |
| Short % of float | 18.1% | 23.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).